Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
33.81
-0.20 (-0.59%)
Oct 13, 2026, 10:40 AM EDT - Market open

Oscar Health Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Oscar Health stock has a consensus rating of "Hold" and an average price target of $36.4. The average 1-year stock price forecast is 7.66% higher than the current stock price, while the lowest is $27 (-20.14%) and the highest is $49 (+44.93%).

Price Target: $36.4 (+7.66%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$27$36.4$34$49
Change-20.14%+7.66%+0.56%+44.93%

Analyst Ratings

The average analyst rating for Oscar Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy000000
Buy233333
Hold777777
Sell111111
Strong Sell100000
Total111111111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Hold
Maintains
$26 → $36
HoldMaintains$26 → $36+6.48%Oct 12, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$48
BuyMaintains$48+41.97%Sep 23, 2026
Raymond James
Raymond James
Buy
Maintains
n/a
BuyMaintainsn/an/aSep 22, 2026
Jefferies
Jefferies
Hold
Maintains
$31
HoldMaintains$31-8.31%Sep 17, 2026
Robert W. Baird
Robert W. Baird
Hold
Maintains
$27 → $33
HoldMaintains$27 → $33-2.40%Sep 17, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
18.73B
from 11.70B
Increased by 60.08%
Revenue Next Year
20.78B
from 18.73B
Increased by 10.95%
EPS This Year
1.94
from -1.69
EPS Next Year
2.22
from 1.94
Increased by 14.26%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.89B3.96B5.86B9.18B11.70B18.73B
Revenue Growth
384.43%109.27%47.92%56.54%27.50%60.08%
Net Income
-572.61M-606.28M-270.73M25.43M-443.15M671.45M
EPS
-----1.691.94
Forward PE
---28.43278.9417.39
Free Cash Flow
----1.06B3.19B
No. Analysts
-----10
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High18.9B
Avg18.7B
Low18.4B

Revenue Growth

Revenue Growth202620272028
High
61.1%
Avg
60.1%
Low
57.0%

EPS Forecast

EPS202620272028
High2.12
Avg1.94
Low1.80

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-